Transfusions in surgery: Can they further be decreased with recombinant humain erythropoietin?;Transfusions en chirurgie: Peuvent-elles encore etre reduites par l'erythropoietine humaine recombinante?

Annales Francaises d'Anesthesie et de Reanimation

Volumn 15, Issue 8, 1996, Pages 1219-1229

  Janvier, G ^a   Roth, C ^a   Benillan N ^a   Fialon, P ^a   Berty, A ^a   Puntous, M ^a  

^a Groupe Hospitalier Sud CHU de Bordeaux   (France)

Author keywords

recombinant human erythropoietin; surgery; transfusion

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANEMIA; BLOOD TRANSFUSION; CANCER; DRUG INDICATION; HEART DISEASE; HUMAN; KIDNEY FAILURE; REVIEW; SAFETY;

EID: 0030470408     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0750-7658(97)85883-2     Document Type: Article

References (62)

1. 1 Goodnough LT, Vizmeg K, Riddell J, Soegiarso RW. Discharge haematocrit as clinical indicator for blood transfusion audit in surgery patients. Transfusion Med 1994;4:35-44
2. 2 Stehling L, Luban NLC, Anderson KC, Sayers MH, Long A, Attar S et al. Guidelines for blood utilization review. Transfusion 1994;34:438-48
3. 3 Toy PT. Effectiveness of transfusion audits and practice guidelines. Arch Pathol Lab Med 1994;118:435-7
4. 4 Conférence de Consensus. Utilisation des globules rouges pour la compensation des pertes sanguines en chirurgie de l'adulte. Paris, 17 décembre 1993. Ann Fr Anesth Réanim 1995;14(Suppl 1):1-117
5. 5 Baele PL. Results of the Sanguis study in Belgium. Acta Chir Belg 1994;94 (Suppl):5-61
6. 6 British Committee for Standards in Haematology Blood Transfusion Task Force. Guidelines for administration of blood products: transfusion of infants and neonates. Transfusion Med 1994;4:63-9
7. 7 Barnette RE, Fish DJ, Eisenstaedt RS. Modification of fresh-frozen plasma transfusion practices through educational intervention. Transfusion 1990;30:253-7
8. 8 Despotis GJ, Grishaber JE, Goodnough LT. The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgery. Transfusion 1994;34:290-6
9. 9 Giovanetti AM, Parravicini A, Baroni L, Riccardi D, Pizzi MN, Almini D et al. Quality assessment of transfusion practice in elective surgery. Transfusion 1988;28:166-9
10. 10 Claverie JP, Roger I, Fialon P, Elizondo C, Janvier G. Gestion du dépôt de sang d'un plateau technique chirurgical du CHU : bilan d'un an d'activité 1994. Ann Fr Anesth Réanim 1995;14(Suppl 3): R 341
11. 11 Tagawa P, Castagnedoli JG, Fulachier V, Gouin F, Auffray JP. Consommation de sang durant la période post-opératoire en chirurgie cardiaque. Évaluation d'une stratégie transfusionnelle. Ann Fr Anesth Réanim 1995;14 (Suppl 3): R 344
12. 12 Baudelot J. Le prélèvement autologue différé en 1995. Nouv Rev Fr Hématol 1995;37 (Suppl 1):S9-S10
13. 13 Biesma DH, Marx JJ, Kraaijenhagen RJ, Franke W, Messinger D, Van de Wiel A. Lower homologous blood requirement in autologous blood donors after treatment with recombinant human erythropoietin. Lancet 1994;344:367-70
14. 14 Triulzi DJ, Gilmor GD, Ness PM, Baumgartner WA, Schultheis LW. Efficacy of autologous fresh whole blood or platelet-rich plasma in adult cardiac surgery. Transfusion 1995;35:627-34
15. 15 Laupacis A. Bailley W. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement (Canadian orthopaedic perioperative erythropoietin study group). Lancet 1993;341:1227-32
16. 16 Cosgrove DM, Heric B, Lytle BW, Taylor PC, Novoa R, Golding LAR et al. Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. Ann Thorac Surg 1992;54:1031-8
17. 17 Levy JH, Bailey JM, Salmenperä M. Pharmacokinetics of aprotinin in preoperative cardiac surgical patients. Anesthesiology 1994;80:1013-8
18. 18 Griffiths EM, Kaplan DK, Goldstraw P, Burman JF. Review of blood transfusion practices in thoracic surgery. Ann Thorac Surg 1994;57:736-9
19. 19 Bracey AW, Radovancevic R, Radovancevic B, McAllister HA, Vaughn WK, Cooley DA. Blood use in patients undergoing repeat coronary artery bypass graft procedures: multivariate analysis. Transfusion 1995;35:850-4
20. 20 Viele MK, Weiskopf RD. What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah's Witness. Transfusion 1994;34:396-401
21. 21 Fullerton DA, Campbell DN, Whitman GJR. Use of human recombinant erythropoietin to correct severe preoperative anemia. Ann Thorac Surg 1991;51:825-6
22. 22 Rothstein P, Roye D, Verdisco L, Stern L. Preoperative use of erythropoietin in an adolescent Jehovah's witness. Anesthesiology 1990;73:568-70
23. 23 Estioko MR, Litwak RS, Rand JH. Reoperation, emergency and urgent open cardiac surgery in Jehovah's witnesses. Chest 1992;102:50-3
24. 24 Akingbola OA, Custer JR, Bunchman TE, Sedman AB. Management of severe anemia without transfusion in a pediatric Jehovah's Witness patient. Crit Care Med 1994;22:524-8
25. 25 Mac Nicol. Bleeding and surgeon experience. Anaesth Intensive Care 1994;22:668-74
26. 26 Paonc G, Spencer T, Silverman NA. Blood conservation in coronary artery surgery. Surgery 1994;116:672-8
27. 27 Biesma DH, Kraaijenhagen RJ, Marx JJ, Van de Wiel A. The efficacy of subcutaneous recombinant human erythropoietin in the correction of phlebotomy-induced anemia in autologous blood donors. Transfusion 1993;33:825-9
28. 28 Spivak JL. The application of recombinant human erythropoietin in anemic patients with cancer. Semin Oncol 1992;19 (Suppl 8):25-8
29. 29 Levine EA, Rosen AL, Sehgal LR, Gould SA, Egrie JC, Sehgal HL et al. Treatment of acute postoperative anemia with recombinant human erythropoietin. J Trauma 1989;29:1134-9
30. 30 Mourad G, Chong G, Cristol JP, Lorho R, Ramounau-Pigot A. Seignalet J. Post-transfusional anti-HLA hyperimmunization: importance of erythropoietin. Nephrology 1993;14:91-4
31. 31 Schmidt R, Kupin W, Dumler F, Venkat KK, Mozes M. Influence of the pretransplant hematocrit level on early graft function in primary cadaveric renal transplantation. Transplantation 1993;55:1034-40
32. 32 Hisatomi K, Isomura T, Galli SJ, Yasunaga H, Hayashida N, Ohishi K. Augmentation of interleukin-2 production after cardiac operations in patients treated with erythropoietin. J Thorac Cardiovasc Surg 1992;104:278-83
33. 33 Erslev AJ. Erythropoietin. N Engl J Med 1991;324:1339-44
34. 34 Link H, Boogaerts MA, Fauser AA, Slavin S, Reiffers J, Gorin NC et al. A controlled trial of recombinant human erythropoietin after bone marrow transplantation. Blood 1994;84:3327-35
35. 35 Fischl M, Galpin JE, Levine JD, Groopman JE, Henry DH, Abel RI et al. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 1990;322:1488-93
36. 36 Bush OR, Hop WC, Hoynck MA, Marquet RL, Jeekel J. Perioperative blood transfusion and outcome after resection of colorectal cancer. N Engl J Med 1993;328:1372-6
37. 37 Heiss MM, Mempel W, Delanoff C, Jauch KW, Gabka C, Mempel M. Blood transfusion-modulaled tumor recurrence: first results of a randomized study of autologous versus allogenic blood transfusion in colorectal cancer. J Clin Oncol 1994;12:1859-67
38. 38 Houbiers JG, Brand A, Van de Wareing LM, Hermans J, Verwey PJ, Bijnen AB. Randomized controlled trial comparing transfusion of leucocyte-depleted or buffy-coat depleted blood in surgery for colorectal cancer. Lancet 1994;344:573-8
39. 39 Laupacis A, Feagan B, Wong C. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet 1993;342:378
40. 40 D'Ambra MM, Lynch RE, Boccagno J, Vlahakes GJ. The effect of perioperative administration of recombinant human erythropoietin (r-HuEPO) in CABG patients: a double blind, placebo-controlled trial. Anesthesiology 1992;77:A159
41. 41 Konishi T, Ohbahashi T, Kaneko T, Ohki T, Saitou Y, Yamato Y. Preoperative use of erythropoietin for cardiovascular operations in anemia. Ann Thorac Surg 1993;56:101-3
42. 42 Mason NA, Iacobellis DP. Drug usage evaluation of epoetin in chronic renal failure. Hosp Formul 1992;27:928-38
43. 43 Beris P, Mermillod B, Levy G, Laubriat M, Soulier-Lauper M, Tullen E et al. Recombinant human erythropoietin as adjuvant treatment for autologous blood donation. A prospective study. Vox Sang 1993;65:212-8
44. 44 Goodnough LT, Verbrugge D, Marcus RE, Goldberg V. The effect of patient size and dose of recombinant human erythropoietin therapy on red blood cell volume expansion in autologous blood donors for elective orthopedic operation. J Am Coll Surg 1994;179:171-6
45. 45 Mercuriali F, Zanella A, Barosi G, Inghilleri G, Biffi E, Vinci A et al. Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion 1993;33:55-60
46. 46 Mercuriali F, Adamson JW. Recombinant human erythropoietin enhances blood donation for autologous use and reduces exposure to homologous blood during elective surgery. Sem Hematol 1993;30:17-21
47. 47 Mercuriali F, Inghilleri G, Biffi E, Colotti MT, Vinci A, Scalamogna R et al. Erythropoietin treatment to increase autologous blood donation in patients with low basal hematocrit undergoing elective orthopedic surgery. Clin Invest 1994;72:S16-S8
48. 48 Mercuriali F, Inghilleri G, Biffi E, Vinci A, Colotti MT, Scalamogna R. The potential role of oxygen-carrying products in autologous blood transfusion protocols. Artif Cell Blood Substi Immobil Biotechnol 1994;22:245-51
49. 49 Rule S, Erber W. Epoetin in elective hip replacement. Lancet 1993;341:1665
50. 50 Saikawa I, Hotokebuchi T, Arita C, Inaba S, Shuto T, Tsutsui H et al. Autologous blood transfusion with recombinant erythropoietin treatment: 22 arthroplasties for rheumatoid arthritis. Acta Orthopaedica Scand 1994;65:15-9
51. 51 Tate DE, Friedman RJ. Blood conservation in spinal surgery. Review of current techniques. Spine 1992;17:1450-6
52. 52 Kulier AH, Gombotz H, Fuchs G, Vuckovic U, Metzler H. Subcutaneous recombinant human erythropoetin and autologous blood donation before coronary artery bypass surgery. Anesth Analg 1993;76:102-6
53. 53 Kyo S, Omoto R, Hirashima K, Eguchi S, Fujita T. Effect of human recombinant erythropoietin on reduction of homologous blood transfusion in open-heart surgery. A Japanese multicenter study. Circulation 1992;86 (Suppl 2):II 413-II 8
54. 54 Love TR, Hendren WC, O'Keefe OD. Transfusion of predonated autologous blood in elective cardiac surgery. Ann Thorac Surg 1987;43:508-12
55. 55 Schomeckel M, Nollert G, Mempem M, Mempel W, Reichart B. Effects of recombinant erythropoietin on autologous blood donation before open heart surgery. Thorac Cardiovasc Surg 1993;41:364-8
56. 56 Shinonaga M, Hayashi J, Shinada S, Nakazawa S. Effect of recombinant human erythropoietin on reduce of homologous blood transfusion in open heart surgery. Kyobu Geka 1990;43:276-9
57. 57 Watanabe Y, Fuse K, Konishi T, Kobayasi T, Takazawa K, Konishi H et al. Autologous blood transfusion with recombinante human erythropoietin in heart operations. Ann Thorac Surg 1991;51:767-72
58. 58 Watanabe Y, Fuse K, Naruse Y, Kobayashi T, Yamamoto S, Konishi H et al. Subcutaneous use of erythropoietin in heart surgery. Ann Thorac Surg 1992;54:479-84
59. 59 Watanabe Y, Fuse K, Naruse Y, Kobayashi T, Shibata Y. Cardiac surgery without homologous blood transfusion. The effectiveness and the indication of recombinant human erythropoietin. J Jap Assoc Thorac Surg 1994;42:499-507
60. 60 Kajikawa M, Nonami T, Kurokawa T, Hashimoto S, Harada A, Nakao A et al. Autologous blood transfusion for hepatectomy in patients with cirrhosis and hepatocellular carcinoma: use of recombinante human erythropoietin. Surgery 1994;115:727-34
61. 61 Yamawaki T, Tanaka H, Takeuchi S, Yanase H, Taniguchi H, Toyoda N. Autologous blood transfusion using recombinant human erythropoietin. Asia Oceania J Obstet Gynaecol 1994;20:147-53
62. 62 Etchason J, Petz L, Keeler E, Calhoun L, Kleinman S, Snider C et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med 1995;332:719-24